Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biolargo Inc BLGO

Chemicals Specialty Chemicals
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company operates through six segments: ONM Environmental, Clyra Medical Technologies (Clyra Medical), BioLargo Engineering (BLEST), BioLargo Canada, Inc. (Canada), BioLargo Energy Technologies, Inc. (BETI), and BioLargo Equipment Solutions & Technologies, Inc. (BEST). ONM Environmental... see more

Recent & Breaking News (OTCQX:BLGO)

BioLargo's Year-to-Date Revenues Up 80%

Accesswire 9 days ago

BioLargo Q3 2024 Earnings Results Webcast and Conference Call on Thursday, November 14, 2024 - 4:30 PM Eastern Time

Accesswire 11 days ago

BioLargo, Inc. to Present at the LD Micro Main Event XVII

Newsfile October 28, 2024

BioLargo Validates Key Performance Metrics of Its Cellinity Battery Energy Storage Technology

Accesswire October 14, 2024

Gabelli Funds to Host 2nd Annual PFAS Symposium at The Harvard Club, New York, NY

GlobeNewswire September 23, 2024

BioLargo to Host Ribbon-Cutting Event for Battery Pilot Manufacturing Facility

Accesswire September 16, 2024

Clyra Medical Technologies, a Subsidiary of BioLargo, Appoints Dr. Steven J. Kavros as Chief Medical Officer

Accesswire September 9, 2024

Gabelli Funds to Host 2nd Annual PFAS Symposium at The Harvard Club, New York, NY

GlobeNewswire September 9, 2024

BioLargo Earnings Results Webcast and Conference Call on Wednesday, August 14, 2024 - 1:30 PM Pacific Time

Accesswire August 13, 2024

BioLargo Achieves Record Quarterly Revenue of $5 Million for Second Quarter of 2024

Accesswire August 6, 2024

BioLargo Engineering Increases Ongoing Revenue with Another Air Force Contract

Accesswire June 20, 2024

BioLargo Subsidiary Clyra Medical Selects Keystone Industries to Support Manufacturing of its Medical Products

Accesswire June 12, 2024

BioLargo Manufactures First Cellinity Battery Cells, a Safer Alternative to Lithium-ion

Accesswire June 11, 2024

BioLargo Engineering Secures Multi-Year Air Force Base Air Compliance Project

Accesswire June 7, 2024

BioLargo Generates Positive Operating Cash Flow on Record Quarterly Revenues for First Quarter of 2024

Accesswire May 14, 2024

OTC Markets Group Welcomes BioLargo, Inc. to OTCQX

GlobeNewswire May 13, 2024

BioLargo Q1 2024 Earnings Results Webcast and Conference Call on Tuesday, May 14, 2024 - 5:30 PM Eastern Time

Accesswire May 10, 2024

EPA Adds PFAS to CERCLA (Superfund) Law, Favoring Low-Waste Systems like BioLargo's AEC

Accesswire April 23, 2024

BioLargo PFAS Removal Technology Meets New US Drinking Water Standards

Accesswire April 15, 2024

BioLargo Achieved 108% Year-Over-Year Revenue Growth in 2023

Accesswire April 2, 2024